News
34m
Korea JoongAng Daily on MSNCelltrion Q2 operating profit more than triples on high-margin biosimilarsCelltrion, a major Korean biopharmaceutical firm, estimated that its second-quarter operating profit more than tripled from a ...
The market co<span id="cke_bm_2024E" style= ntinues to see strong appetite for larger office spaces and an evolving mix of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results